High-dose N-acetylcysteine in an immunocompromised patient with COVID-19: a case report.

Lai, K Y; Au, S Y; Sin, K C; Yung, S K; Leung, A K H

Lai, K Y; Au, S Y; Sin, K C; Yung, S K; Leung, A K H.

Afiliación

Lai KY; Department of Intensive Care, Queen Elizabeth Hospital, Hong Kong SAR, China.
Au SY; Cardiovascular Centre, St Paul's Hospital, Hong Kong SAR, China.
Sin KC; Department of Intensive Care, Queen Elizabeth Hospital, Hong Kong SAR, China.
Yung SK; Department of Intensive Care, Queen Elizabeth Hospital, Hong Kong SAR, China.
Leung AKH; Department of Intensive Care, Queen Elizabeth Hospital, Hong Kong SAR, China.

Hong Kong Med J ; 30(1): 69-71, 2024 Feb.

Article en En | MEDLINE | ID: mdl-38327160

Asunto(s)

Acetilcisteína; COVID-19; Humanos; Acetilcisteína/uso terapéutico; Huésped Inmunocomprometido; Antioxidantes

Palabras clave

Acetylcysteine; Adult; Antioxidants; COVID-19

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acetilcisteína / COVID-19 Límite: Humans Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google